関連する実験動画

Updated: May 30, 2026

Exploring Arterial Smooth Muscle Kv7 Potassium Channel Function using Patch Clamp Electrophysiology and Pressure Myography

Exploring Arterial Smooth Muscle Kv7 Potassium Channel Function using Patch Clamp Electrophysiology and Pressure Myography

Published on: September 14, 2012

1次高血圧および2次高血圧におけるKv7.4チャネル活動のダウンレギュレーション

Thomas A Jepps¹, Preet S Chadha, Alison J Davis

¹Division of Biomedical Sciences, St. George's, University of London, United Kingdom.

|July 13, 2011

まとめ

電圧誘導のカリウムチャネル (Kv7チャネル) は血管トーンを調節するが,高血圧モデルでは下調調節される. この研究では,高血圧のラットとマウスのKv7チャネル機能を調査し,反応が低下し,Kv7.4タンパク質レベルが低下した.

科学分野:

心血管生理学心血管の生理学
分子心臓病学分子心臓病学
薬理学薬理学とは

背景:

KCNQ遺伝子 (Kv7チャネル) によってコードされた電圧ゲートされたカリウムチャネルは,血管の血管トーンを調節する重要なレギュレーターです.
血管疾患におけるKv7チャネルの機能的影響は,依然としてほとんど不明である.

研究の目的:

構造的に異なる3つのKv7チャネル活性化剤 (BMS-204352,S-1,およびレチガビン) が,正常血圧および高血圧の動物の血管に及ぼす効果を確かめる.
高血圧のモデルにおけるKv7チャネルの機能的影響と発現を調査する.

主な方法:

静脈のリラックスと冠動脈の perfusion 試験は,胸部大動脈,中腹動脈のセグメント,および normotensive と自発的に高血圧のラット (SHRs) からLangendorff 心臓製剤を使用して実施されました.
隔離されたメゼンテリック動脈の神経細胞のカリウム電流を測定した.
KCNQ遺伝子とKv7.4タンパク質の発現レベルは,正常血圧と高血圧のラットとマウスの血管組織で分析されました.

主要な成果:

3つのKV7活性化剤はすべて,前もって収縮した血管をリラックスさせ,正常血圧の動物における冠動脈 perfusion を増加させた.
Kv7活性化剤が血管をリラックスさせ,冠動脈の流れを増加させ,K ((+)) 流を増加させる能力は,SHRsとアンジオテンシンIIを注入したマウスの組織において有意に低下していた.
KCNQ4遺伝子の発現が低下し,Kv7.4タンパク質のレベルは高血圧のネズミとマウスの血管組織で,正常血圧の対照群と比較して有意に低下しました.

結論:

Kv7チャネルの機能的影響は,2つの異なるラットとマウスの高血圧モデルで劇的に低下しています.
Kv7.4タンパク質のレベルが低下し,経路機能が低下すると,高血圧における血管機能障害に寄与する.

さらに関連する動画

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes

Published on: March 12, 2013

Recording of Inward Rectifying K+ Currents in Freshly Isolated Basilar Artery Smooth Muscle Cells by Patch Clamp Technique

Recording of Inward Rectifying K⁺ Currents in Freshly Isolated Basilar Artery Smooth Muscle Cells by Patch Clamp Technique

Published on: February 7, 2025

関連する概念動画

Hypertension and Regulation of Blood Pressure

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...

Antihypertensive Drugs: Potassium-Sparing Diuretics

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...

Antihypertensive Drugs: Action of β1 Blockers

Antihypertensive Drugs: Action of β₁ Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...

Antihypertensive Drugs: Action of Calcium Channel Blockers

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...

Antihypertensive Drugs: Angiotensin II Receptor Blockers

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...

Hypertension II: Pathophysiology

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...